Ligand · MH7
MH7 · N-butyl-2-(butylamino)-4-[(trans-4-hydroxycyclohexyl)amino]-N-methylpyrimidine-5-carboxamide
MH7, N-butyl-2-(butylamino)-4-[(trans-4-hydroxycyclohexyl)amino]-N-methylpyrimidine-5-carboxamide (C20 H35 N5 O2, 377.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- MH7
- Formula
- C20 H35 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
MH7 in 2 structures; the first of them:
- 4MH7 · Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase… · MH7 A906 · binds LEU593, GLY594, GLU595, GLY596, VAL601, ALA617, ILE650, LEU671 and 8 more
- 4MH7 · Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase… · MH7 A906 · binds LEU593, GLY594, GLU595, GLY596, VAL601, ALA617, ILE650, LEU671 and 8 more
Residues it binds most
GLY 2, ALA 2, LEU 2, MET 2, GLU 2, ILE 2, LYS 2, PHE 2, PRO 2, TYR 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.